NDC Package 50242-059-01 Bevacizumab

Liquid - View Billable Units, 11-Digit Format, RxNorm

Package Information
Other Packages
Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

50242-059-01

Package Description:

120 L in 1 TANK

Product Code:

50242-059

Non-Proprietary Name:

Bevacizumab

Substance Name:

Bevacizumab

Usage Information:

This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.

11-Digit NDC Billing Format:

50242005901

Product Type:

Drug For Further Processing

Labeler Name:

Genentech, Inc.

Dosage Form:

Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.

Active Ingredient(s):

BEVACIZUMAB 25 g/L

Sample Package:

N/A

Marketing Category:

DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.

Start Marketing Date:

02-26-2004

Listing Expiration Date:

12-31-2024

Exclude Flag:

Unfinished Product:

Yes

Code Structure:

50242 - Genentech, Inc.
- 50242-059 -
  - 50242-059-01 - 120 L in 1 TANK

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package Code	Package Description
50242-059-02	300 L in 1 TANK

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 50242-059-01?

The NDC Packaged Code 50242-059-01 is assigned to an UNFINISHED drug package of 120 l in 1 tank of Bevacizumab, drug for further processing labeled by Genentech, Inc.. The product's dosage form is liquid and is administered via form.

Is NDC 50242-059 included in the NDC Directory?

Yes, Bevacizumab is an UNFINISHED PRODUCT with code 50242-059 that is active and included in the NDC Directory. The product was first marketed by Genentech, Inc. on February 26, 2004 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 50242-059-01?

The 11-digit format is 50242005901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	50242-059-01	5-4-2	50242-0059-01

Table of Contents